//Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine

Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine

After completing their graduate work at Stanford, Trevor Martin and Ashley Tehranchi took 2 benches at MBC BioLabs to launch Mammoth Biosciences. Now, only seven months later, they and their colleagues have completed a $23M Series A. Mammoth Biosciences is turning UC Berkeley professor, Jennifer Doudna’s latest CRISPR discoveries into an innovative diagnostics platform. The research portion of the company will include Berkeley PhD students Janice Chen and Lucas Harrington at the helm.

MBC BioLabs and Mission Bay Capital are thrilled to have been able to help this terrific team of entrepreneurial scientists go from start to data and financing in such short order.

2018-12-11T11:55:28+00:00August 7th, 2018|Startup News|